Comorbilidades en la esclerosis múltiple y su influencia en la elección del tratamiento / Comorbidities in multiple sclerosis and their influence on the choice of treatment

Los estudios clínicos de tratamientos para personas con esclerosis múltiple (pEM) se realizan en poblaciones seleccionadas, que excluyen a pacientes que presenten comorbilidades o medicaciones concomitantes. Sin embargo, un gran porcentaje de las pEM tiene alguna enfermedad adicional, que podría afectar a la respuesta y la elección del tratamiento. El objetivo de esta revisión es valorar cómo pueden las diferentes patologías concurrentes impactar en la elección de las terapias modificadoras de la enfermedad (TME) en las pEM. Se seleccionaron artículos relevantes mediante búsqueda en PubMed. Las comorbilidades se agruparon, a los fines de mejor ordenamiento de los artículos encontrados, en patologías diversas: autoinmunes, infecciones crónicas, cardiovasculares, respiratorias, metabólicas, oncológicas, neuropsiquiátricas y epilepsia. En cuanto a las patologías autoinmunes, es clave tener en cuenta los efectos de las TME sobre ellas y la posibilidad de interacción con sus tratamientos específicos. Las terapias inmunomoduladoras son seguras para personas con infecciones crónicas. Los tratamientos inmunosupresores, en general, están contraindicados en personas con infecciones activas. En las comorbilidades cardiovasculares y metabólicas deben tenerse en cuenta las potenciales reacciones de infusión asociadas a anticuerpos monoclonales, y los fenómenos asociados al inicio de tratamiento con moduladores del receptor de la esfingosina-1-fosfato. Las TME con efecto inmunosupresor están contraindicadas en personas con malignidades activas. Aunque la patología psiquiátrica de por sí no impide el uso de TME, debería tenerse precaución cuando aparecen nuevos síntomas psiquiátricos, y siempre tenerse en cuenta su monitorización y tratamiento. Por este motivo, entre los múltiples factores que deben considerarse a la hora de iniciar o cambiar una TME en pEM, las comorbilidades constituyen un elemento muchas veces decisivo.(AU)

Clinical trials of disease-modifying therapies (DMTs) for people with multiple sclerosis (pMS) are conducted in selected populations, excluding patients with comorbidities or concomitant medications. However, a large percentage of pMS have some additional disease, which could affect the response and choice of the DMT. The objective of this review is to assess how concurrent pathologies can impact the choice of DMTs. Relevant articles were selected through a systematic search in PubMed. Comorbidities were grouped for better classification into autoimmune, chronic infections, cardiovascular and metabolic, oncological and neuropsychiatric. In autoimmune pathologies, it is key to take into account the effects of TME on them and the possibility of interaction with their specific treatments. Immunomodulatory therapies are safe for people with chronic infections. Immunosuppressive treatments are generally contraindicated in people with active infections. In cardiovascular and metabolic comorbidities, infusion reactions associated with monoclonal antibodies, and the phenomena of starting treatment with S1P modulators, must be taken into account. DMTs with an immunosuppressive effect are contraindicated in people with active malignancies. Although psychiatric pathology per se does not preclude the use of DMTs, caution should be exercised when new psychiatric symptoms appear. For these reasons, among the multiple factors that must be considered when starting or changing a DMT in pMS, comorbidities constitute a decisive element.(AU)

Multimorbidity and use of health services in a population diagnosed with COVID-19 in a municipality in the Southern Region of Brazil, 2020-2021: a cross-sectional study / Multimorbilidad y uso de servicios de salud en una población diagnosticada con covid-19 en un municipio de la región sur de Brasil, 2020-2021: estudio transversal / Multimorbidade e uso de serviços de saúde em população diagnosticada com covid-19 em município da região Sul do Brasil, 2020-2021: estudo transversal

Abstract Objective: To assess association between multimorbidity and use of health services in a population diagnosed with COVID-19, in southern Brazil. Methods: This was a cross-sectional study with data from a longitudinal study carried out in the city of Rio Grande, Rio Grande do Sul, Brazil, in 2021 with all adult individuals diagnosed with COVID-19; descriptive analyses were performed and presented as proportions with 95% confidence intervals (95%CI); Poisson regression was performed and reported as prevalence ratios (PR) in order to assess association between multimorbidity (3 or more diseases) and healthcare service use. Results: In total, 2,919 participants were included, of which 40.4% had multimorbidity (≥ 2 diseases); the adjusted results showed that individuals with multimorbidity were more likely to use most of the services assessed, PR = 3.21 (95%CI 1.40;7.37), for Emergency Rooms. Conclusion: Multimorbidity was associated with using different types of health services.

Resumen Objetivo: Analizar la asociación entre multimorbilidad y uso de servicios de salud en una población diagnosticada con COVID-19, en el Sur de Brasil. Métodos: Estudio transversal con datos de un estudio longitudinal realizado en la ciudad de Río Grande, Rio Grande do Sul, Brasil, en el año 2021, con todos los individuos adultos diagnosticados con COVID-19; se realizaron análisis descriptivos y se presentaron como proporciones con intervalos de confianza del 95% (IC95%); se realizó una regresión de Poisson y se informó como razón de prevalencia (PR). Resultados: En total se incluyeron 2.919 participantes, de los cuales el 40,4% presentaba multimorbilidad (≥ 2 doenças); los resultados ajustados mostraron que los individuos con multimorbilidad tenían mayor probabilidad de utilizar la mayoría de los servicios evaluados, RP = 3,21 (IC95% 1,40;7,37) para unidades Primeros auxilios. Conclusión: La multimorbilidad se asoció con el uso de diferentes tipos de servicios de salud.

Resumo Objetivo: Analisar a associação entre multimorbidade e uso de serviços de saúde em uma população diagnosticada com covid-19, no Sul do Brasil. Métodos: Estudo transversal, utilizando-se dados de um estudo longitudinal realizado na cidade de Rio Grande, estado do Rio Grande do Sul, Brasil, em 2021, com todos os indivíduos adultos diagnosticados com covid-19; análises descritivas foram realizadas e apresentadas como proporções com intervalos de confiança de 95% (IC95%); a regressão de Poisson foi realizada e relatada como razão de prevalências (RP), para avaliar a associação entre multimorbidade e utilização de serviços de saúde. Resultados: Dos 2.919 participantes, 40,4% apresentavam multimorbidade (≥ 2 doenças); os resultados ajustados mostraram que indivíduos com multimorbidade (3 ou mais doenças) apresentaram maior probabilidade de utilização da maioria dos serviços avaliados (RP = 3,21; IC95% 1,40;7,37) em unidades de pronto-socorro. Conclusão: A multimorbidade esteve associada à utilização de diferentes tipos de serviços de saúde.

Pharmacotherapeutic follow-up of a patient with multimorbities: experience report / Acompanhamento farmacoterapêutico em paciente com multimorbidades: um relato de experiência / Seguimiento farmacoterapéutico en pacientes con multimorbilidad: informe de una experiencia

Chronic non-communicable diseases are growing global health problems. The objective of this study was to promote pharmaceutical care for a patient with multimorbidities in order to improve its quality of life. A pharmacotherapeutic follow-up was performed using the SOAP method, registered in the form of clinical evolution, along with laboratory tests, anthropometric measurements and application of validated instruments to assess pharmacological adherence, mental health and quality of life. The report deals with a female patient, 55 years old, obese and dyslipidemic, sedentary, hypertensive, diabetic and on the control phase of breast cancer. Self-medication with antibiotics and a proton pump inhibitor was identified. Despite the good pharmacological adherence, the patient had decompensated diabetes, accompanied by dyslipidemia without treatment and interruption of supplements. After pharmacological and non- pharmacological interventions, the patient showed a significant improvement in the reduction of anthropometric measurements and in biochemical parameters. At the end of the follow-up, pharmaceutical care proved to be fundamental in identifying the patient's health problems, contributing to obtain a more rational pharmacotherapy.

As doenças crônicas não transmissíveis são problemas de saúde globais crescentes. O objetivo deste estudo foi promover a assistência farmacêutica a um paciente com multimorbidades, a fim de melhorar sua qualidade de vida. Foi realizado acompanhamento farmacoterapêutico pelo método SOAP e aplicação de instrumentos validados para avaliar adesão farmacológica, saúde mental e qualidade de vida. O relato trata de uma paciente do sexo feminino, 55 anos, obesa e dislipidêmica, sedentária, hipertensa, diabética e em fase de controle do câncer de mama. Foi identificada automedicação com antibióticos e inibidor de bomba de prótons. Apesar da boa adesão farmacológica, a paciente apresentava diabetes descompensado, acompanhada de dislipidemia sem tratamento e interrupção das suplementações. Após intervenções farmacológicas e não farmacológicas, a paciente apresentou melhora significativa na redução das medidas antropométricas e nos parâmetros bioquímicos. Ao final do acompanhamento, a assistência farmacêutica mostrou-se fundamental na identificação dos problemas de saúde do paciente.

Las enfermedades crónicas no transmisibles constituyen un creciente problema de salud mundial. El objetivo de este estudio fue promover la asistencia farmacéutica a un paciente con multimorbilidades para mejorar su calidad de vida. Se realizó seguimiento farmacoterapéutico por el método SOAP y aplicación de instrumentos validados para evaluar adherencia farmacológica, salud mental y calidad de vida. O relato trata de uma paciente do sexo feminino, 55 anos, obesa e dislipidêmica, sedentária, hipertensa, diabética e em fase de controle do câncer de mama. Se identificó automedicación con antibióticos e inhibidor de la bomba de protones. A pesar del buen cumplimiento farmacológico, la paciente presentó diabetes descompensada, acompañada de dislipidemia no tratada e interrupción de la suplementación. Tras intervenciones farmacológicas y no farmacológicas, la paciente mostró una mejoría significativa en la reducción de las medidas antropométricas y los parámetros bioquímicos. Al final del seguimiento, la asistencia farmacéutica demostró ser fundamental en la identificación de los problemas de salud del paciente.

Estudio multicéntrico sobre multimorbilidad en internados en áreas clínicas / Multicenter Study on Multimorbidity in Patients in Clinical Areas

Introducción: El estudio de la comorbilidad requiere de un enfoque multilateral con vistas a mejorar la calidad de la atención de los enfermos por el sistema de atención. Objetivos: Explorar la magnitud de la comorbilidad de enfermedades crónicas en adultos internados en los hospitales. Métodos: Se realizó un estudio prospectivo-observacional-longitudinal-analítico. Se incluyeron pacientes internados en las Salas de Clínica Médica o pacientes clínicos en Salas de Internación Indiscriminada. Se realizó un estudio multicéntrico en 42 centros en un período de 2 años, con un muestreo consecutivo. Para el estudio se tuvo en cuenta la estadística descriptiva, inferencial y de regresión. Resultados: El total de pacientes en el estudio fue de 5925, masculinos con el 50,3 por ciento de edad 60,66 ± 0,25 años. Principal procedencia desde la guardia el 73 por ciento. La estadía hospitalaria de 12,61 ± 0,24 días, mayormente en pacientes quirúrgicos (15,45 ± 0,67 vs 11,76 ± 0,23; p < 0,00001). El 23 por ciento recibió tratamiento quirúrgico. El principal nivel educativo: secundario completo 21,6 por ciento. Dificultades económicas: 20 por ciento, mortalidad 9,26 por ciento; prevalencia de dislipemia, diabetes e hipertensión: 22,53 por ciento; 28,82 por ciento y 51,86 por ciento con 473 nuevos diagnósticos, IMC: 27,88 ± 0,65, Charlson global 2,09 ± 0,02 y en óbitos 3,84 ± 0,11. La media de patologías por paciente fue de 2,14 ± 0,01 y aumentó con la edad (p valor regresión lineal < 0,00001). Conclusiones: La hipertensión, la diabetes y la dislipemia representaron las entidades más prevalentes en Salas de Internación Clínica, Las enfermedades cardiovasculares, respiratorias, infectológicas, oncológicas, neurológicas, metabólicas y nefrológicas fueron predictores independientes de mortalidad(AU)

Introduction: The study of comorbidity requires a multilateral approach with a view to improving the quality of care for these patients by the care system. Objectives: To explore the magnitude of the comorbidity of chronic diseases in adults admitted to hospitals. Methods: Prospective-observational-longitudinal-analytical study. Patients hospitalized in a medical clinic room or clinical patients in indiscriminate hospitalization rooms are included, Multicenter study in 42 centers, with 2 years of recruitment. Consecutive sampling. Descriptive, inferential and regression statistics. Results: 5925 recruited, male gender 50,3percent, age 60,66 ± 0,25 years, main origin from the guard 73percent, stay 12,61 ± 0,24 days, longer in surgical (15,45 ± 0,67 vs 11,76 ± 0,23, p < 0,00001), 23percent received surgical treatment. Main educational level: complete secondary school 21,6%. Economic difficulties: 20percent, mortality 9,26percent, prevalence of dyslipidemia, diabetes and hypertension: 22,53percent, 28,82percent and 51,86percent with 473 new diagnoses in said pathologies, BMI: 27,88 ± 0,65, Global Charlson 2,09 ± 0,02 and in deaths 3,84 ± 0,11. The average number of pathologies per patient was 2,14 ± 0,01 and increased with age (p value for linear regression < 0,00001). Conclusions: Hypertension, diabetes and dyslipidemia represented the most prevalent entities in the clinical hospitalization room, cardiovascular, respiratory, infectious, oncological, neurological, metabolic and nephrological diseases were independent predictors of mortality(AU)

Tratamientos modificadores de la enfermedad en pacientes con esclerosis múltiple en España / Disease-modifying treatments for patients with multiple sclerosis in Spain

La esclerosis múltiple es una enfermedad desmielinizante crónica del sistema nervioso central y discapacitante a largo plazo. Existen diferentes tratamientos modificadores de la enfermedad. Estos pacientes, a pesar de ser generalmente jóvenes, tienen una elevada comorbilidad y riesgo de polimedicación por su compleja sintomatología y discapacidad. Objetivo principal determinar el tipo de tratamiento modificador de la enfermedad en los pacientes atendidos en servicios de farmacia de hospitales españoles. Objetivos secundarios Conocer los tratamientos concomitantes, determinar la prevalencia de la polifarmacia, identificar la prevalencia de interacciones y analizar la complejidad farmacoterapéutica. Método estudio observacional, transversal y multicéntrico. Se incluyeron todos los pacientes con diagnóstico de esclerosis múltiple y tratamiento modificador de la enfermedad activo a los que se atendió en las consultas de pacientes externos o en los hospitales de día durante la segunda semana de febrero 2021. Se recogieron: el tratamiento modificador, las comorbilidades y los tratamientos concomitantes para determinar el patrón de multimorbilidad, polifarmacia, complejidad farmacoterapéutica (Medication Regimen Complexity Index) e interacciones medicamentosas. Resultados se incluyeron 1.407 pacientes de 57 centros de 15 Comunidades Autónomas. La forma de presentación de la enfermedad más frecuente fue la forma remitente recurrente (89,3%). El tratamiento modificador de la enfermedad más prescrito fue dimetilfumarato (19,1%), seguido de teriflunomida (14,0%). De los tratamientos modificadores parenterales, los 2 más prescritos fueron el acetato de glatiramero y el natalizumab con un 11,1 y 10,8% respectivamente. El 24,7% de los pacientes tenían una comorbilidad y el 39,8% al menos 2 comorbilidades. El 13,3% pertenecía al menos a uno de los patrones definidos de multimorbilidad y el 16,5% pertenecían a 2 o más patrones. ... (AU)

Multiple sclerosis is a chronic demyelinating disease of the central nervous system and long-term disabling. Different disease-modifying treatments are available. These patients, despite being generally young, have high comorbidity and risk of polymedication due to their complex symptomatology and disability.Objective primaryTo determine the type of disease-modifying treatment in patients seen in Spanish hospital pharmacy departments.Secondary objectivesTo determine concomitant treatments, determine the prevalence of polypharmacy, identify the prevalence of interactions and analyse pharmacotherapeutic complexity.MethodObservational, cross-sectional, multicentre study. All patients with a diagnosis of multiple sclerosis and active disease-modifying treatment who were seen in outpatient clinics or day hospitals during the second week of February 2021 were included. Modifying treatment, comorbidities and concomitant treatments were collected to determine multimorbidity pattern, polypharmacy, pharmacotherapeutic complexity (Medication Regimen Complexity Index) and drug-drug interactions.Results1,407 patients from 57 centres in 15 autonomous communities were included. The most frequent form of disease presentation was the relapsing remitting form (89.3%). The most prescribed disease-modifying treatment was dimethyl fumarate (19.1%), followed by teriflunomide (14.0%). Of the parenteral disease-modifying treatments, the two most prescribed were glatiramer acetate and natalizumab with 11.1% and 10.8%. 24.7% of the patients had one comorbidity and 39.8% had at least 2 comorbidities. 13.3% belonged to at least one of the defined patterns of multimorbidity and 16.5% belonged to 2 or more patterns. The concomitant treatments prescribed were psychotropic drugs (35.5%); antiepileptic drugs (13.9%) and antihypertensive drugs and drugs for cardiovascular pathologies (12.4%). ... (AU)

Clinical and functional assessment in patients admitted with pluripathological dysphagia according to the mode of feeding: Through a gastrostomy tube or oral.

INTRODUCTION: Multipathological patients are a vulnerable population with high comorbidity, functional impairment, and nutritional risk. Almost 50% of these hospitalized patients have dysphagia. There is no consensus on whether placement of a percutaneous endoscopic gastrostomy (PEG) tube provides greater clinical benefit. The purpose of this study was to know and compare 2 groups of multipathological patients with dysphagia according to the mode of feeding: PEG vs. oral. METHOD: Retrospective descriptive study with hospitalized patients (2016-19), pluripathological, with dysphagia, nutritional risk, over 50 years with diagnoses of: dementia, cerebrovascular accident (CVA), neurological disease, or oropharyngeal neoplasia. Terminally ill patients with jejunostomy tube or parenteral nutrition were excluded. Sociodemographic variables, clinical situation, and comorbidities were evaluated. Bivariate analysis was performed to compare both groups according to their diet, establishing a significance level of p < .05. RESULTS: 1928 multipathological patients. The PEG group consisted of 84 patients (n122). A total of 84 were randomly selected to form the non-PEG group (n434). This group had less history of bronchoaspiration/pneumonia (p = .008), its main diagnosis was stroke versus dementia in the PEG group (p < .001). Both groups had more than a 45% risk of comorbidity (p = .77). CONCLUSIONS: multipathological patients with dysphagia with PEG usually have dementia as their main diagnosis, however, stroke is the most relevant pathology in those fed orally. Both groups have associated risk factors, high comorbidity, and dependence. This causes their vital prognosis to be limited regardless of the mode of feeding.

[Translated Article] Disease-modifying treatments for patients with multiple sclerosis in Spain.

Multiple sclerosis is a chronic demyelinating disease of the central nervous system and long-term disabling. Different disease-modifying treatments are available. These patients, despite being generally young, have high comorbidity and risk of polymedication due to their complex symptomatology and disability. OBJECTIVE PRIMARY: To determine the type of disease-modifying treatment in patients seen in Spanish hospital pharmacy departments. SECONDARY OBJECTIVES: to determine concomitant treatments, determine the prevalence of polypharmacy, identify the prevalence of interactions and analyze pharmacotherapeutic complexity. METHOD: Observational, cross-sectional, multicentre study. All patients with a diagnosis of multiple sclerosis and active disease-modifying treatment who were seen in outpatient clinics or day hospitals during the second week of February 2021 were included. Modifying treatment, comorbidities and concomitant treatments were collected to determine multimorbidity pattern, polypharmacy, pharmacotherapeutic complexity (Medication Regimen Complexity Index) and drug-drug interactions. RESULTS: 1407 patients from 57 centres in 15 autonomous communities were included. The most frequent form of disease presentation was the relapsing remitting form (89.3%). The most prescribed disease-modifying treatment was dimethyl fumarate (19.1%), followed by teriflunomide (14.0%). Of the parenteral disease-modifying treatments, the two most prescribed were glatiramer acetate and natalizumab with 11.1% and 10.8%. 24.7% of the patients had 1 comorbidity and 39.8% had at least 2 comorbidities. 13.3% belonged to at least one of the defined patterns of multimorbidity and 16.5% belonged to 2 or more patterns. The concomitant treatments prescribed were psychotropic drugs (35.5%); antiepileptic drugs (13.9%) and antihypertensive drugs and drugs for cardiovascular pathologies (12.4%). The presence of polypharmacy was 32.7% and extreme polypharmacy 8.1%. The prevalence of interactions was 14.8%. Median pharmacotherapeutic complexity was 8.0 (IQR: 3.3-15.0). CONCLUSIONS: We have described the disease-modifying treatment of patients with multiple sclerosis seen in Spanish pharmacy services and characterized concomitant treatments, the prevalence of polypharmacy, interactions, and their complexity.

Disease-modifying treatments for patients with multiple sclerosis in Spain. / Tratamientos modificadores de la enfermedad en pacientes con esclerosis múltiple en España.

Multiple sclerosis is a chronic demyelinating disease of the central nervous system and long-term disabling. Different disease-modifying treatments are available. These patients, despite being generally young, have high comorbidity and risk of polymedication due to their complex symptomatology and disability. OBJECTIVE PRIMARY: To determine the type of disease-modifying treatment in patients seen in Spanish hospital pharmacy departments. SECONDARY OBJECTIVES: To determine concomitant treatments, determine the prevalence of polypharmacy, identify the prevalence of interactions and analyse pharmacotherapeutic complexity. METHOD: Observational, cross-sectional, multicentre study. All patients with a diagnosis of multiple sclerosis and active disease-modifying treatment who were seen in outpatient clinics or day hospitals during the second week of February 2021 were included. Modifying treatment, comorbidities and concomitant treatments were collected to determine multimorbidity pattern, polypharmacy, pharmacotherapeutic complexity (Medication Regimen Complexity Index) and drug-drug interactions. RESULTS: 1,407 patients from 57 centres in 15 autonomous communities were included. The most frequent form of disease presentation was the relapsing remitting form (89.3%). The most prescribed disease-modifying treatment was dimethyl fumarate (19.1%), followed by teriflunomide (14.0%). Of the parenteral disease-modifying treatments, the two most prescribed were glatiramer acetate and natalizumab with 11.1% and 10.8%. 24.7% of the patients had one comorbidity and 39.8% had at least 2 comorbidities. 13.3% belonged to at least one of the defined patterns of multimorbidity and 16.5% belonged to 2 or more patterns. The concomitant treatments prescribed were psychotropic drugs (35.5%); antiepileptic drugs (13.9%) and antihypertensive drugs and drugs for cardiovascular pathologies (12.4%). The presence of polypharmacy was 32.7% and extreme polypharmacy 8.1%. The prevalence of interactions was 14.8%. Median pharmacotherapeutic complexity was 8.0 (IQR: 3.3 -- 15.0). CONCLUSIONS: We have described the disease-modifying treatment of patients with multiple sclerosis seen in Spanish pharmacy services and characterised concomitant treatments, the prevalence of polypharmacy, interactions, and their complexity.

Multimorbidade e fatores associados em adultos usuários da Atenção Primária à Saúde no norte do Rio Grande do Sul / Multimorbidity and associated factors in adult users of Primary Health Care in northern Rio Grande do Sul, Brazil / Multimorbidad y factores asociados en adultos en usuarios de Atención Primaria de Salud en el norte de Rio Grande do Sul

Introdução: As mudanças no estilo de vida levam ao aumento da exposição a fatores de risco a doenças crônicas e, diante disso, torna-se mais frequente a simultaneidade de tais doenças, em idades cada vez mais precoces, o que caracteriza uma condição complexa e desafiadora na área da saúde. Objetivo: Analisar a prevalência e os fatores associados à multimorbidade em usuários da Atenção Primária à Saúde (APS) de Passo Fundo, norte do Rio Grande do Sul, Brasil. Métodos: Realizou-se um estudo transversal, cujos dados foram coletados por meio da aplicação de questionários a adultos atendidos na rede urbana da APS de maio a agosto de 2019. Calculou-se a prevalência do desfecho, com intervalo de confiança de 95% (IC95%) e as razões de prevalência (RP) brutas e ajustadas, visando identificar os fatores associados. Resultados: A prevalência de multimorbidade na amostra de 958 participantes foi de 31% (IC95% 28­34) e seus fatores associados foram idade de 50­59 anos (RP=5,47; IC95% 3,54­8,45), autopercepção negativa de saúde (RP=1,61; IC95% 1,29­2,01), excesso de peso (RP=3,14; IC95% 2,21­4,44) e polifarmácia (RP=1,55; IC95% 1,33­1,81). Conclusão: A multimorbidade é prevalente na população atendida na APS, e sugere-se que as equipes de saúde busquem estratégias de investigação dessa condição e dos fatores que possam estar associados.

Introduction: Lifestyle changes have led to an increased exposure to risk factors for chronic diseases, making the coexistence of such conditions more frequent, even at younger ages. This complex and challenging health condition is characterized by the simultaneous presence of multiple diseases. Objective: To analyze the prevalence and factors associated with multimorbidity in users of Primary Health Care (PHC) in Passo Fundo, northern Rio Grande do Sul, Brazil. Methods: A cross-sectional study was conducted. Data were collected by applying questionnaires to adults assisted by the urban network of PHC from May to August 2019. The prevalence of the outcome was estimated, with a 95% confidence interval (95%CI), as well as crude and adjusted Prevalence Ratios (PR) to identify associated factors. Results: The prevalence of multimorbidity in the sample of 958 participants was 31% (95%CI 28­34), and its associated factors were age between 50 and 59 years (PR=5.47; 95%CI 3.54­8.45), negative self-perception of health (PR=1.61; 95%CI 1.29­2.01), overweight (PR=3.14; 95%CI 2.21­4.44), and polypharmacy (PR=1.55; 95%CI 1.33­1.81). Conclusion: Multimorbidity is prevalent in the population assisted by PHC, suggesting that healthcare teams should seek strategies for investigating this condition and associated factors.

Introducción: Los cambios en el estilo de vida han llevado a un aumento en la exposición a factores de riesgo para enfermedades crónicas, lo que hace más frecuente la coexistencia de tales condiciones, incluso a edades más tempranas. Esta compleja y desafiante condición de salud se caracteriza por la presencia simultánea de múltiples enfermedades. Objetivo: Analizar la prevalencia y los factores asociados a la multimorbilidad en usuarios de la Atención Primaria a la Salud (APS) de Passo Fundo, norte de Rio Grande do Sul, Brasil. Métodos: Se realizó un estudio transversal, y los datos se recopilaron a través de la aplicación de cuestionarios a adultos atendidos en la red urbana de APS de mayo a agosto de 2019. Se calculó la prevalencia del resultado, con un intervalo de confianza del 95% (IC95%), así como las Razones de Prevalencia (RP) crudas y ajustadas para identificar los factores asociados. Resultados: La prevalencia de multimorbilidad en la muestra de 958 participantes fue del 31% (IC95% 28­34), y sus factores asociados fueron edad entre 50 y 59 años (RP=5,47; IC95% 3,54­8,45), percepción negativa de la salud (RP=1,61; IC95% 1,29­2,01), sobrepeso (RP=3,14; IC95% 2,21­4,44) y polifarmacia (RP=1,55; IC95% 1,33­1,81). Conclusión: La multimorbilidad es prevalente en la población atendida en APS, lo que sugiere que los equipos de salud deben buscar estrategias de investigación para esta condición y los factores asociados.

Teoría del Manejo del Síntoma: análisis para investigación en multimorbilidad en ambientes comunitarios / Symptom Management Theory: Analysis for Multimorbidity Research in Community Settings

Objetivo: Analizar críticamente la teoría de rango medio Symptom Management Theory y evaluar su utilidad en la investigación sobre multimorbilidad en ambientes comunitarios. Metodología: Análisis teórico según estrategia de subestructuración de Dulock, consistente en 4 pasos: identificación de constructos y conceptos; descripción de las relaciones; operacionalización de los conceptos con indicadores empíricos y representación pictórica y jerarquizada del modelo. Resultados: El modelo cuenta con una clara estructura jerárquica, vinculando el sistema teórico y operativo. Esta estructura teórica es coherente, sencilla y tiene un respaldo suficiente para ser aplicada en el estudio de la gestión de síntomas en usuarios portadores de multimorbilidad en ambientes comunitarios. Conclusiones: La teoría de rango medio Manejo del Síntoma es útil para el estudio de la multimorbilidad en contextos comunitarios.(AU)

Objective: To critically analyze the middle-range theory Symptom Management Theory and evaluate their utility in research on multimorbidity in community settings. Methodology: Theoretical analysis using Dulock's substruction strategy, consisting of four steps: identification of constructs and concepts, description of relationships, operationalization of concepts with empirical indicators, and hierarchical pictorial representation of the model. Results: The model's hierarchical structure is clear, effectively linking the theoretical and operational systems. This theoretical structure is coherent, straightforward, and sufficiently supported for its application in the study of symptom management in individuals with multimorbidity in community settings. Conclusions: The middle-range theory of Symptom Management is valuable for investigating multimorbidity in community contexts.(AU)

Multimorbidity and the use of health services in the Brazilian population: National Health Survey 2019 / Multimorbilidad y el uso de los servicios de salud en la población brasileña: Encuesta Nacional de Salud 2019 / Multimorbidade e uso de serviços de saúde na população brasileira: Pesquisa Nacional de Saúde 2019

ABSTRACT Objective To describe the prevalence of health service use due to multimorbidity according to sociodemographic and health characteristics of the Brazilian population; to analyze the relationship between multimorbidity and the use of health services. Methods This was a cross-sectional study using data from the 2019 National Health Survey. The outcomes were seeking health services in the last 15 days, medical consultation and hospitalization in the previous 12 months. Multimorbidity was defined as ≥ 2 chronic diseases. Associations were assessed using Poisson regression. Results Of the 81,768 individuals, prevalence of seeking health services among individuals with multimorbidity was 38.0% higher (95%CI 1.31;1.45), medical appointments, 11.0% higher (95%CI 1.10;1.12), and 56.0% higher for hospitalizations (95%CI 1.44;1.70), compared to those without multimorbidity. This relationship was higher for seeking health services and medical appointments among male. Conclusion The use of health services was higher among those with multimorbidity, but different between the types of health services used and sexes.

RESUMEN Objetivo Describir prevalencia de uso de servicios de salud por multimorbilidad según características sociodemográficas de salud de población brasileña; analizar relación entre multimorbilidad y utilización de servicios de salud. Métodos Estudio transversal con datos de Encuesta Nacional de Salud de 2019. Resultados fueron búsqueda de servicios de salud en últimos quince días; consulta médica y hospitalizaciones en últimos doces meses. Multimorbilidad se definió como ≥ 2 enfermedades crónicas. Asociaciones se evaluaron mediante regresión de Poisson. Resultados De los 81.768 individuos, prevalencia de búsqueda de servicios de salud entre los individuos con multimorbilidad fue 38,0% mayor (IC95% 1,31;1,45), citas médicas 11,0% mayor (IC95% 1,10;1,12) y 56,0% mayor para hospitalizaciones (IC95% 1,44;1,70), en comparación con aquellos sin multimorbilidad. Esta relación fue mayor para búsqueda y citas médicas entre el sexo masculino. Conclusión El uso de los servicios de salud fue mayor entre aquellos con multimorbilidad, pero diferente entre los tipos de servicios de salud utilizados y sexos.

RESUMO Objetivo Descrever a prevalência do uso de serviços de saúde por multimorbidade segundo características sociodemográficas e saúde da população brasileira, e analisar a relação entre a multimorbidade e o uso de serviços de saúde. Métodos Estudo transversal utilizando dados da Pesquisa Nacional de Saúde 2019. Os desfechos foram busca por serviços de saúde nos últimos 15 dias, consulta médica e internações nos últimos 12 meses. Multimorbidade foi definida como ≥ 2 doenças crônicas. As associações foram avaliadas pela regressão de Poisson. Resultados Dos 81.768 indivíduos, a prevalência de busca por serviços de saúde entre indivíduos com multimorbidade foi 38% maior (IC95% 1,31;1,45), consultas médicas, 11% maior (IC95% 1,10;1,12), e 56% maior para internações (IC95% 1,44;1,70), em comparação àqueles sem multimorbidade. Essa relação foi maior para busca e consultas médicas no sexo masculino. Conclusão O uso de serviços de saúde foi maior entre aqueles com multimorbidade, mas diferente entre os tipos de serviços de saúde utilizados e sexos.

Traducción y adaptación transcultural al español de la escala MULTIPleS en pacientes de edad avanzada con multimorbilidad / Cross-cultural adaptation into Spanish of the MULTIPleS scale in elderly patients with multimorbidity

Antecedentes y objetivo: La escala Multimorbidity Illness Perceptions Scale (MULTIPleS) analiza si padecer dos o más enfermedades crónicas repercute en la calidad de vida, coste y resultados clínicos de los pacientes. El objetivo fue traducir y adaptar transculturalmente al español la escala MULTIPleS.MétodosTraducción directa y retrotraducción seguidas de síntesis y adaptación por un tercer traductor y un panel de expertos para garantizar la equivalencia conceptual, semántica y de contenido entre ambas versiones. Posteriormente, se realizó un análisis de comprensibilidad en una muestra de pacientes.ResultadosSe obtuvo la versión española de la escala MULTIPleS. El grado de dificultad medio en la traducción directa y la retrotraducción del título y de las preguntas demostró una dificultad baja. En la fase de síntesis y adaptación, se resolvieron 6 discrepancias. El análisis de comprensibilidad se realizó en 10 pacientes, lográndose el requisito establecido (> 80%) para todos los ítems.ConclusionesSe trata de la primera adaptación transcultural al español de la escala MULTIPleS. Disponer de esta escala retrotraducida permitirá analizar la percepción de los pacientes ante la enfermedad y aplicar así mejoras en su asistencia sanitaria. (AU)

Background and objective: The Multimorbidity Illness Perceptions Scale (MULTIPleS) analyzes whether suffering from two or more chronic diseases affects the quality of life, cost and clinical results of patients. The objective was to translate and cross-culturally adapt the MULTIPleS scale into Spanish.MethodsDirect translation and back translation followed by synthesis and adaptation by a third translator and a panel of experts to guarantee the conceptual, semantic and content equivalence between both versions. Subsequently, a comprehensibility analysis was performed on a sample of patients.ResultsThe Spanish version of the MULTIPleS scale was obtained. The medium degree of difficulty in the direct translation and the back translation of the title and the questions showed a low difficulty. In the synthesis and adaptation phase, 6 discrepancies were resolved. The comprehensibility analysis was performed in 10 patients, achieving the established requirement (> 80%) for all items.ConclusionsThis is the first cross-cultural adaptation to Spanish of the MULTIPleS scale. Having this back-translated scale will make it possible to analyze patients’ perception of the disease and thus apply improvements in their healthcare. (AU)

Influencia de la pluripatología y comorbilidad en el ingreso hospitalario en una cohorte de pacientes de una unidad de continuidad asistencial Primaria-Interna / Influence of multipathology and comorbidity on hospital admission in a cohort of patients from a Primary-Internal continuous care unit

Objetivo: estimar la frecuencia de pluripatología y comorbilidad en pacientes seguidos en una unidad de continuidad asistencial Primaria-Interna, así como conocer sus características clínicas y la relación entre pluripatología y comorbilidad con el ingreso hospitalario. Diseño: estudio observacional retrospectivo de casos y controles. Emplazamiento: Unidad de Continuidad Asistencial de Atención Primaria y Medicina Interna (UCAPI) del Complejo Hospitalario Universitario de Albacete. Participantes: se analizaron 1.591 pacientes atendidos en una unidad de continuidad asistencial Primaria-Interna (292 con algún ingreso hospitalario en el último año y 1.299 sin ingresos). Mediciones principales: edad, sexo, problemas de salud, índice de Charlson, consumo de medicamentos y utilización de servicios sanitarios los 3 años previos. Resultados: del total de la muestra, un 18,4% (IC 95%:16,4-20,3) eran casos con algún ingreso. Presentaba pluripatología un 23,3% (IC 95%: 21,1-25,4) y comorbilidad (índice de Charlson ≥ 2) un 32,6% (IC 95%: 30,2-34,9). Fueron variables asociadas de forma independiente a ingreso hospitalario la pluripatología (OR: 2,51; IC 95%: 1,64-3,83; p < 0,001), comorbilidad (índice de Charlson ≥ 2) (OR: 1,81; IC 95%:1,18-2,78; p = 0,006), tener más de tres problemas de salud (OR: 1,49; IC 95%: 1,07-2,07; p = 0,017), contar con mayor número de consultas de Atención Primaria (AP) (OR: 1,01; IC 95%: 1,00-1,02; p = 0,005), de hospital (1,03; IC 95%: 1,01-1,05), p < 0,001) y realizar más visitas a urgencias hospitalarias (OR: 1,12, IC 95%: 1,07-1,17). Conclusiones: casi una cuarta parte de los pacientes seguidos en una unidad de continuidad asistencial entre Medicina interna y de Familia presenta pluripatología y un tercio, comorbilidad. La presencia de pluripatología y comorbilidad son características relacionadas con el ingreso hospitalario, junto con la mayor utilización de servicios sanitarios.(AU)

Objective: to estimate the frequency of multiple pathologies and comorbidity in patients followed up in a Primary-Internal care continuity unit (PICCU), and to ascertain their clinical characteristics and degree of association between multiple pathologies and comorbidity with hospital admission. Design: retrospective case-control observational study. Site: Primary Care and Internal Medicine Continuity of Care Unit (UCAPI) of Albacete Teaching Hospital. Participants: a total of 1591 patients treated in a PICCU (292 with a hospital admission in the last year and 1299 without admission) were analyzed. Main measurements: age, sex, health problems, Charlson index, drug use and use of health services in the previous three years. Results: of the total sample, 18.4% (95% CI: 16.4-20.3) were cases with an admission; 23.3% had multiple pathologies (95% CI: 21.1-25.4) and comorbidity (Charlson index ≥ 2) 32.6% (95% CI: 30.2-34.9). Variables independently associated with hospital admission were multiple pathologies (OR: 2.51; 95% CI: 1.64-3.83; P <0.001), comorbidity (Charlson ≥ 2) (OR: 1.81; 95% CI): 1.18-2.78; P = 0.006), more than three health problems (OR: 1.49; 95% CI: 1.07-2.07; P = 0.017), a higher number of primary care consultations (OR: 1.01; 95% CI: 1.00-1.02; P = 0.005), Hospital (1.03; 95% CI: 1.01-1.05), P < 0.001) and making more visits to the hospital accident and emergency department (OR: 1.12, 95% CI: 1.07-1.17). Conclusions: almost a quarter of patients followed up in a care continuity unit between internal and family medicine presented multiple pathologies and a third presented comorbidity. Multiple pathologies and comorbidity are predictive characteristics of hospital admission together with a greater use of health services.(AU)

Cross-cultural adaptation into Spanish of the MULTIPleS scale in elderly patients with multimorbidity. / Traducción y adaptación transcultural al español de la escala MULTIPleS en pacientes de edad avanzada con multimorbilidad.

BACKGROUND AND OBJECTIVE: The Multimorbidity Illness Perceptions Scale (MULTIPleS) analyzes whether suffering from two or more chronic diseases affects the quality of life, cost and clinical results of patients. The objective was to translate and cross-culturally adapt the MULTIPleS scale into Spanish. METHODS: Direct translation and back translation followed by synthesis and adaptation by a third translator and a panel of experts to guarantee the conceptual, semantic and content equivalence between both versions. Subsequently, a comprehensibility analysis was performed on a sample of patients. RESULTS: The Spanish version of the MULTIPleS scale was obtained. The medium degree of difficulty in the direct translation and the back translation of the title and the questions showed a low difficulty. In the synthesis and adaptation phase, 6 discrepancies were resolved. The comprehensibility analysis was performed in 10 patients, achieving the established requirement (> 80%) for all items. CONCLUSIONS: This is the first cross-cultural adaptation to Spanish of the MULTIPleS scale. Having this back-translated scale will make it possible to analyze patients' perception of the disease and thus apply improvements in their healthcare.

Automanejo en personas con multimorbilidad: aportes desde la salutogénesis y el modelo de activos en salud / Self-management in people with multimorbility: Contributions from salutogenesis and health assets model

Diferentes modelos de cuidado en contexto de cronicidad y multimorbilidad incorporan a la comunidad, sistema de salud, práctica clínica, políticas sanitarias, prevención y promoción de salud. Entre estos se señala el rol facilitador del equipo de salud en el automanejo, siendo las personas protagonistas de su proceso. El abordaje de la multimorbilidad se realiza mayormente desde un enfoque centrado en el riesgo y la enfermedad, limitando la exploración de los recursos de las personas y su entorno. Incorporar un enfoque de salud positiva puede aportar a una mayor integralidad. El propósito de este artículo es proponer un abordaje desde el modelo sinérgico de salud, integrando la salutogénesis y el modelo de activos, para facilitar el automanejo promoviendo la capacidad de agencia de las personas. Se presentan potenciales áreas de aplicación de estos modelos en el contexto de multimorbilidad, fomentando condiciones de salud y bienestar en las personas y sus familias.(AU)

Different models of care in context of chronicity and multimorbidity include community, health system, clinical practice, health policies, prevention, and health promotion. Among these, the role of the health team as a facilitator of self-management is pointed out, being people the protagonists of their process. Multimorbidity approach is mostly carried out from a risk and disease focused point of view, which limits the exploration of resources of people and their environment. Incorporating a positive health approach can contribute to a greater comprehensiveness. The purpose of this article is to propose an approach from the synergy model of health, integrating salutogenesis and health assets model, to help facilitate self-management promoting people's agency capacity. Potential areas of application of these models are presented to work in the context of multimorbidity, promoting health and well-being conditions in people and their families.(AU)

Multimorbilidad y síndromes geriátricos. Su efecto sobre la mortalidad en adultos mayores con sepsis / Multimorbidity and geriatric syndromes. Their effect on mortality in older adults with sepsis

Resumen Introducción: la sepsis se diagnostica en más de 60% de los adultos mayores (AM) en el mundo. Estos AM con frecuencia presentan multimorbilidad y alguno de los síndromes geriátricos, llevando a discapacidad física, cognitiva y psicosocial, lo cual produce altos costos para los sistemas de salud, resultando en un problema grave de salud pública. Objetivo: identificar el impacto de la multimorbilidad y los síndromes geriátricos en la morta lidad de AM hospitalizados por sepsis en una unidad geriátrica de agudos a 30 días de su ingreso. Material y métodos: estudio observacional, analítico de casos y controles anidado en una cohorte. Resultados: se analizaron 238 pacientes con edad media de 83.15±7.12 años, 52.1% fueron mujeres y el 99% tenían al menos una comorbilidad, la mortalidad a 30 días fue 34%. La infección urinaria fue la causa principal de hospitalización (42.9%), obteniendo un aislamiento microbio-lógico en 43.3% de los casos, siendo la Escherichia coli el agente causal más frecuente (46.6%). La regresión logística múltiple mostró que la enfermedad renal crónica (OR 2.1 IC 95% 1.1-4.8; p=0.037), el delirium (OR 3.1 IC 95% 1.6-5.8; p=0.001) y la discapacidad (índice de Barthel <60; OR 3.4 IC 95% 1.5-7.5; p=0.002) se asociaron de manera significativa con la mortalidad a 30 días desde el ingreso a la unidad geriátrica de agudos en paciente con sepsis. Conclusión: en los AM hospitalizados por sepsis, la multimorbilidad, la enfermedad re nal crónica y los síndromes geriátricos representados por delirium y discapacidad fueron los predictores de mortalidad a 30 días. (Acta Med Colomb 2022; 47. DOI:https://doi.org/10.36104/amc.2022.2125).

Abstract Introduction: sepsis is diagnosed in more than 60% of older adults (OAs) worldwide. These OAs often have multimorbidity and one of the geriatric syndromes, leading to physical, cognitive and psychosocial disability with consequently high healthcare costs, resulting in a serious public health problem. Objective: to determine the impact of multimorbidity and geriatric syndromes on the 30-day mortality rate of OAs hospitalized for sepsis in an acute geriatric unit Materials and methods: an observational, analytical, nested case-control study. Results: 238 patients with a mean age of 83.15±7.12 were analyzed; 52.1% were women and 99% had at least one comorbidity; the 30-day mortality was 34%. Urinary tract infection was the main cause of hospitalization (42.9%), with microbiological isolation achieved in 43.3% of cases and Escherichia coli being the most common causal agent (46.6%). Multiple logistic regression showed that chronic kidney disease (OR 2.1 95% CI 1.1-4.8; p=0.037), delirium (OR 3.1 95% CI 1.6-5.8; p=0.001) and disability (Barthel index <60; OR 3.4 95% CI 1.5-7.5; p=0.002) were significantly related to 30-day mortality in patients with sepsis admitted to an acute geriatric unit. Conclusion: in OAs hospitalized for sepsis, multimorbidity, chronic kidney disease and geriatric syndromes (represented by delirium and disability) were the predictors of 30-day mortality. (Acta Med Colomb 2022; 47. DOI:https://doi.org/10.36104/amc.2022.2125).

[Self-management in people with multimorbility: Contributions from salutogenesis and health assets model]. / Automanejo en personas con multimorbilidad: aportes desde la salutogénesis y el modelo de activos en salud.

Different models of care in context of chronicity and multimorbidity include community, health system, clinical practice, health policies, prevention, and health promotion. Among these, the role of the health team as a facilitator of self-management is pointed out, being people the protagonists of their process. Multimorbidity approach is mostly carried out from a risk and disease focused point of view, which limits the exploration of resources of people and their environment. Incorporating a positive health approach can contribute to a greater comprehensiveness. The purpose of this article is to propose an approach from the synergy model of health, integrating salutogenesis and health assets model, to help facilitate self-management promoting people's agency capacity. Potential areas of application of these models are presented to work in the context of multimorbidity, promoting health and well-being conditions in people and their families.

Multimorbidity and health care of community health workers in Vitória, Espírito Santo, Brazil, 2019: a cross-sectional study / Multimorbilidad y atención de la salud de los agentes comunitarios de salud en Vitória, Espírito Santo, Brasil, 2019: un estudio transversal / Multimorbidade e cuidado com a saúde de agentes comunitários de saúde em Vitória, Espírito Santo, 2019: um estudo transversal

Objective: To evaluate health conditions, health care and life habits of community health workers (CHW) in Vitória, Espírito Santo, Brazil. Methods: Cross-sectional study of baseline data from an intervention study. Biochemical, anthropometric, hemodynamic examinations were carried out and an interview was conducted between October/2018 and March/2019 in Vitória. Appropriate statistical tests, according to the sample design, were performed using SPSS software version 21.0, adopting p<0.05. Results: Evaluated 262 CHW with a mean age of 46.1±9.3 years. High prevalence of pre-diabetes(22.9%), diabetes mellitus (17.2%), hypertension (37,0%), obesity (39.8%), hypercholesterolemia (57.3%), hypertriglyceridemia (27.1%), multimorbidity (40.8%), physical inactivity (60.9%) and use of anxiolytics/ antidepressants (22.5%). About 40% of CHW had three or more morbidities. Conclusion: High percentages of chronic diseases, multimorbidity, sedentary lifestyle and use of anxiolytics/antidepressants were observed in CHW in Vitória.

Objetivo: Evaluar condiciones de salud, cuidados de la salud y hábitos de vida de los Agentes Comunitarios de Salud (ACS) en Vitória, Espírito Santo, Brasil. Métodos: Estudio transversal de la línea de base de un estudio de intervención. Se realizaron clínicos y entrevistas entre octubre/2018 y marzo/2019 en Vitória. Se realizaron las pruebas estadísticas adecuadas utilizando el software SPSS versión 21.0, adoptando p<0.05. Resultados: Se evaluaron 262 ACS, con una edad promedio de 46,1±9,3 años. Hubo altas prevalencias de prediabetes (22,9%), diabetes mellitus (17,2%), hipertensión arterial (37,0%), obesidad (39,8%), hipercolesterolemia (57,3%), hipertrigliceridemia (27,1%), multimorbilidad (40,8%), inactividad física (60,9%) y uso de ansiolíticos/antidepresivos (22,5%). Aproximadamente el 40% tenía tres o más enfermedades. Conclusión: Se observaron altos porcentajes de enfermedades crónicas, multimorbilidad, sedentarismo y uso de ansiolíticos/antidepresivos en los ACS de Vitória.

Objetivo: Avaliar condições de saúde, cuidados com a saúde e hábitos de vida de agentes comunitários de saúde (ACS) de Vitória, Espírito Santo, Brasil. Métodos: Estudo transversal da linha de base de um estudo de intervenção. Foram realizados exames bioquímicos, antropométricos, hemodinâmicos e entrevistas, entre outubro/2018 e março/2019, em Vitória. Testes estatísticos apropriados, conforme o delineamento da amostra, foram realizados utilizando-se o software SPSS versão 21.0, e adotando-se p<0,05. Resultados: Foram avaliados 262 ACS com idade média de 46,1±9,3 anos. Observaram-se elevados percentuais de pré-diabetes (22,9%), diabetes mellitus (17,2%), hipertensão arterial (37,0%), obesidade (39,8%), hipercolesterolemia (57,3%), hipertrigliceridemia (27,1%), multimorbidade (40,8%), sedentarismo (60,9%) e uso de ansiolíticos/antidepressivos (22,5%). Cerca de 40% dos ACS apresentaram três ou mais morbidades. Conclusão: Foram observados elevados percentuais de doenças crônicas, multimorbidade, sedentarismo e uso de ansiolíticos/antidepressivos em ACS de Vitória

Multimorbilidad y resultados clínicos de una población pediátrica con sospecha de COVID-19 atendida en un hospital mexicano / Multimorbidity and clinical results of a pediatric population with suspected COVID-19 treated in a Mexican hospital

Resumen Introducción: Datos de varios países del mundo sugieren que los niños con COVID-19 podrían presentar síntomas diferentes y menos graves que los adultos. Sin embargo, los patrones epidemiológicos y clínicos en este grupo poblacional son poco claros. Métodos: El presente es un estudio observacional, con una caracterización inicial transversal-analítica, y con un componente longitudinal o de seguimiento a un grupo de menores con sospecha y/o diagnóstico confirmado de COVID-19, que presentaron desenlaces como mejoría, traslado a un nivel superior de atención o defunción por sintomatología respiratoria. Los niños recibieron atención médica en el Hospital General Regional con Medicina Familiar N.° 1 (HGR C/MF N.° 1), y se les realizó prueba de reacción en cadena de la polimerasa en tiempo real (RT-PCR). Resultados: Se estudiaron 98 niños como casos sospechosos para COVID-19, a quienes se les realizó RT-PCR. Del total, 24 resultaron positivos y 74 fueron negativos. La mediana de edad de los participantes fue 64,4 meses (0 a 203 meses), 55 menores eran de sexo masculino, 59 niños tuvieron manejo ambulatorio, y de estos, 14 presentaron resultado positivo. Entre los que requirieron manejo hospitalario (39), 10 niños dieron positivo para SARS-CoV-2, 84,7% alcanzaron mejoría y fueron dados de alta, 4 fueron trasladados a hospitales de nivel superior de atención. De los 98 niños en estudio, 11 fallecieron, 7 con resultado negativo y 4 con resultado positivo para SARS-CoV-2. Conclusiones: Los principales síntomas de la población pediátrica en este estudio fueron fiebre, tos y malestar general. De los niños que fallecieron, 4 presentaron resultado positivo para SARS-CoV-2, no obstante, estos presentaban otras comorbilidades.

Abstract Introduction: Data from several countries around the world suggest that children with COVID-19 may present different and less severe symptoms than adults. However, the epidemiological and clinical patterns in this population group have been unclear. Methods: This is an observational study, with an initial cross-analytical characterization, and with a longitudinal or follow-up component in a group of minors with suspected and or confirmed case of COVID-19, which have outcomes such as improvement, transfer to a higher level of care or death due to respiratory symptoms. The children received medical attention at the Regional General Hospital with Family Medicine No 1 (HGR C / MF No 1), and underwent a Real Time Polymerase Chain Reaction test (RT-PCR). Results: 98 children were studied as suspected cases for COVID-19, who underwent RT-PCR. Of the total 24 were positive and 74 were negatives. The median age was 64.4 months (0 to 203 months), 55 minors were male, 59 children had outpatient management, and of these, 14 had a positive result. Among those who required hospital management (39), 10 children were positive for SARS-CoV-2, 84.7% achieved improvement and were discharged, and four were transferred to a higher level of care hospital. Of the 98 children in the study, 11 died, seven had a negative result and four a positive result for SARS-CoV-2. Conclusions: The main symptoms of the pediatric population in this study were fever, cough and general discomfort. Four of those who died had a positive result for SARS-CoV-2, however, they had other comorbidities.

Multimorbidade e cuidado com a saúde de agentes comunitários de saúde em Vitória, Espírito Santo, 2019: um estudo transversal / Multimorbilidad y atención de la salud de los agentes comunitarios de salud en Vitória, Espírito Santo, Brasil, 2019: un estudio transversal / Multimorbidity and health care of community health workers in Vitória, Espírito Santo, Brazil, 2019: a cross-sectional study

Objetivo: Avaliar condições de saúde, cuidados com a saúde e hábitos de vida de agentes comunitários de saúde (ACS) de Vitória, Espírito Santo, Brasil. Métodos: Estudo transversal da linha de base de um estudo de intervenção. Foram realizados exames bioquímicos, antropométricos, hemodinâmicos e entrevistas, entre outubro de 2018 e março de 2019, em Vitória. Testes estatísticos apropriados, conforme o delineamento da amostra, foram realizados utilizando-se o software SPSS versão 21.0, e adotando-se p<0,05. Resultados: Foram avaliados 262 ACS com idade média de 46,1±9,3 anos. Observaram-se elevados percentuais de pré-diabetes (22,9%), diabetes mellitus (17,2%), hipertensão arterial (37,0%), obesidade (39,8%), hipercolesterolemia (57,3%), hipertrigliceridemia (27,1%), multimorbidade (40,8%), sedentarismo (60,9%) e uso de ansiolíticos/antidepressivos (22,5%). Cerca de 40% dos ACS apresentaram três ou mais morbidades. Conclusão: Foram observados elevados percentuais de doenças crônicas, multimorbidade, sedentarismo e uso de ansiolíticos/antidepressivos em ACS de Vitória.

Objetivo: Evaluar condiciones de salud, cuidados de la salud y hábitos de vida de los agentes comunitarios de salud (ACS) en Vitória, Espírito Santo, Brasil. Métodos: Estudio transversal de la línea de base de un estudio de intervención. Se realizaron clínicos y entrevistas entre octubre de 2018 y marzo de 2019 en Vitória. Se realizaron las pruebas estadísticas adecuadas utilizando el software SPSS versión 21.0, adoptando p<0,05. Resultados: Se evaluaron 262 ACS, con una edad promedio de 46,1±9,3 años. Hubo altas prevalencias de prediabetes (22,9%), diabetes mellitus (17,2%), hipertensión arterial (37,0%), obesidad (39,8%), hipercolesterolemia (57,3%), hipertrigliceridemia (27,1%), multimorbilidad (40,8%), inactividad física (60,9%) y uso de ansiolíticos/antidepresivos (22,5%). Aproximadamente el 40% tenía tres o más enfermedades. Conclusión: Se observaron altos porcentajes de enfermedades crónicas, multimorbilidad, sedentarismo y uso de ansiolíticos/antidepresivos en los ACS de Vitória.

Objective: To assess health conditions, health care and lifestyle habits of community health workers (CHW) in Vitória, Espírito Santo, Brazil. Methods: This was a cross-sectional study using baseline data from an intervention study. Biochemical, anthropometric and hemodynamic examinations and interviews were carried out between October 2018 and March 2019 in Vitória. Appropriate statistical tests, in accordance with the sample design, were performed using SPSS software version 21.0, adopting p<0,05. Results: We assessed 262 CHWs with a mean age of 46.1±9.3 years. High prevalence of prediabetes (22.9%), diabetes mellitus (17.2%), hypertension (37.0%), obesity (39.8%), hypercholesterolemia (57.3%), hypertriglyceridemia (27.1%), multimorbidity (40.8%), physical inactivity (60.9%) and use of anxiolytics/antidepressants (22.5%) was found. Some 40% of the CHWs had three or more morbidities. Conclusion: High percentages of chronic diseases, multimorbidity, sedentary lifestyle and use of anxiolytics/antidepressants were found in CHWs in Vitória.